Adding clinical markers of more severe form of intermediate-high risk pulmonary embolism improves risk stratification and possibly identifies candidates for fibrinolytic therapy
Propensity score adjusted analysis of the association of thrombolytic therapy and 30-days outcome in patients with intermediate risk pulmonary embolism
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
